# A Phase II Clinical Study of AC-201 Tablets in Subjects With Plaque Psoriasis

> **NCT06972888** · PHASE2 · COMPLETED · sponsor: **Accro Bioscience (Suzhou) Limited** · enrollment: 145 (actual)

## Conditions studied

- Plaque Psoriasis

## Interventions

- **DRUG:** AC-201
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06972888
- **Lead sponsor:** Accro Bioscience (Suzhou) Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-04-23
- **Primary completion:** 2025-03-07
- **Final completion:** 2025-04-28
- **Target enrollment:** 145 (ACTUAL)
- **Last updated:** 2025-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06972888

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06972888, "A Phase II Clinical Study of AC-201 Tablets in Subjects With Plaque Psoriasis". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06972888. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*